Journal of Gynecologic Oncology

Scope & Guideline

Driving Excellence in Gynecologic Oncology Studies

Introduction

Welcome to your portal for understanding Journal of Gynecologic Oncology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2005-0380
PublisherKOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY
Support Open AccessYes
CountrySouth Korea
TypeJournal
Convergefrom 2009 to 2024
AbbreviationJ GYNECOL ONCOL / J. Gynecol. Oncol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address102-HO, 55-5, NONHYEON-DONG, GANGNAM-GU, SEOUL 135-010, SOUTH KOREA

Aims and Scopes

The Journal of Gynecologic Oncology focuses on advancing research and clinical practices in the field of gynecologic cancers, emphasizing innovative treatments, surgical techniques, and comprehensive patient care.
  1. Ovarian Cancer Management:
    Research and clinical guidelines focusing on the treatment, surgery, and management of ovarian cancers, including the use of novel therapies like PARP inhibitors and surgical techniques.
  2. Cervical Cancer Research:
    A significant focus on cervical cancer, including screening, treatment protocols, and innovative surgical techniques, highlighting the importance of early detection and effective management.
  3. Endometrial Cancer Studies:
    In-depth studies on endometrial cancer, including prognostic factors, molecular classifications, and the development of treatment guidelines for various stages of the disease.
  4. Minimally Invasive Surgical Techniques:
    Exploration and clinical evaluation of minimally invasive surgical approaches in gynecologic oncology, including robotic surgeries and laparoscopic methods, aimed at improving patient outcomes.
  5. Immunotherapy and Precision Medicine:
    Investigation of immunotherapeutic strategies and the application of precision medicine in treating gynecologic cancers, underscoring the shift towards personalized treatment plans.
  6. Epidemiology and Outcomes Research:
    Analysis of epidemiological trends and patient outcomes in gynecologic cancers, contributing to a better understanding of risk factors and treatment efficacy.
Recent publications in the Journal of Gynecologic Oncology highlight several emerging trends and themes that reflect the journal's responsiveness to advancements in research and clinical practice.
  1. PARP Inhibitor Research:
    Increased focus on PARP inhibitors and their role in managing ovarian cancer, particularly in frontline maintenance therapies and overcoming resistance, showcasing a significant shift in treatment paradigms.
  2. Guideline Development and Standardization:
    Emerging trends in the formulation of clinical guidelines by various oncology societies, indicating a collaborative approach to standardizing care and improving treatment outcomes across regions.
  3. Integration of Genetic and Molecular Profiling:
    A rising emphasis on genetic and molecular profiling in diagnosing and treating gynecologic cancers, paving the way for tailored therapies that enhance patient management.
  4. Self-Sampling Techniques for HPV Testing:
    Growing interest in self-sampling methods for HPV testing, particularly in low-resource settings, as part of broader initiatives to improve cervical cancer screening access.
  5. Prognostic Biomarkers and Models:
    An emerging focus on developing and validating prognostic models and biomarkers that can predict treatment responses and patient outcomes, facilitating personalized medicine.

Declining or Waning

As the field of gynecologic oncology evolves, certain themes are becoming less prominent in recent publications, reflecting changing research priorities and advancements in treatment.
  1. Traditional Chemotherapy Approaches:
    There is a noticeable decline in studies focusing solely on traditional chemotherapy regimens, as newer targeted therapies and immunotherapies gain precedence in treatment discussions.
  2. Basic Surgical Techniques:
    Research concentrating on basic surgical techniques is waning as more emphasis is placed on advanced minimally invasive and robotic surgeries that enhance recovery and outcomes.
  3. General Screening Practices:
    While screening remains critical, there is a shift away from general screening practices towards more specific and targeted screening methods, particularly involving HPV and personalized risk assessments.
  4. Longitudinal Studies on Older Treatment Protocols:
    Fewer publications focus on older treatment protocols that have been largely replaced by newer, more effective strategies, indicating a transition towards contemporary practices.

Similar Journals

ZENTRALBLATT FUR CHIRURGIE

Your Essential Resource for Surgical Excellence
Publisher: GEORG THIEME VERLAG KGISSN: 0044-409XFrequency: 6 issues/year

Zentralblatt für Chirurgie is a pivotal journal in the realm of surgical medicine, serving as an essential resource for researchers, professionals, and students in the field. Published by Georg Thieme Verlag KG, this journal has been disseminating vital surgical research since its inception in 1947, fostering a robust dialogue among healthcare practitioners worldwide. While currently positioned in the Q4 quartile for both Medicine and Surgery in 2023, Zentralblatt für Chirurgie remains a valuable platform for disseminating innovative findings, case studies, and critical reviews that shape contemporary surgical practices. With a rich archive and a commitment to enhancing surgical knowledge, this journal is ideally suited for those seeking to stay abreast of current trends and developments within the medical landscape. Although it does not provide open access, its contents continue to be a crucial asset for institutions and professionals dedicated to surgical excellence.

Annals of Gastroenterological Surgery

Unlocking New Horizons in Gastroenterological Surgery
Publisher: WILEY-V C H VERLAG GMBHISSN: 2475-0328Frequency: 6 issues/year

Annals of Gastroenterological Surgery is a premier open-access journal published by WILEY-V C H VERLAG GMBH, dedicated to advancing the field of gastrointestinal surgery through innovative research, comprehensive reviews, and clinical studies. Since its inception in 2017, the journal has quickly established itself as a leading platform, achieving a commendable Q1 ranking in both Gastroenterology and Surgery, with significant impact reflected in its Scopus Ranks, positioning it within the 87th and 69th percentiles, respectively. With its focus on high-quality, accessible research, the Annals of Gastroenterological Surgery invites researchers, professionals, and students from around the globe to contribute and share their findings, ensuring that important advancements in surgical techniques and patient care are broadly disseminated. The journal's open-access model enhances its reach and impact, enabling a wider audience to benefit from cutting-edge developments in the field. As the journal converges towards its 2024 volume, it continues to uphold the highest standards in publication, making it an indispensable resource for anyone involved in the disciplines of gastroenterology and surgical practice.

INTERNATIONAL SURGERY

Unveiling Insights for Tomorrow's Surgical Leaders
Publisher: INT COLLEGE OF SURGEONSISSN: 0020-8868Frequency: 4 issues/year

INTERNATIONAL SURGERY, published by the International College of Surgeons, is a vital resource in the field of surgical medicine, with an ISSN of 0020-8868. Established in 1966, this journal serves as a platform for researchers and practitioners to share innovative surgical techniques, critical studies, and reviews that shape the future of surgical practices worldwide. Although it currently resides in the Q4 category of Surgery for 2023, the journal is committed to fostering the dissemination of knowledge, urging authors to contribute to its growth and influence. Situated in the United States at 1516 N Lake Shore Dr, Chicago, IL 60610, INTERNATIONAL SURGERY aims to bridge the gap between emerging surgical trends and clinical application. While it does not offer open access options, the journal's archives are a treasure trove of wisdom for both seasoned professionals and students who seek to deepen their understanding of the surgical domain. Join us in exploring the challenges and advancements within surgery, as we work towards enhancing patient care and surgical outcomes.

Indian Journal of Urology

Advancing Urological Knowledge, One Study at a Time.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-1591Frequency: 4 issues/year

Indian Journal of Urology, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to the field of urology, serving as a vital platform for researchers and clinicians to disseminate groundbreaking findings since its inception in 2001. With an ISSN of 0970-1591 and an E-ISSN of 1998-3824, this journal has established itself as a crucial resource for advancing knowledge in urological practices, particularly within the Indian context. Recognized in the 2023 Scopus Rankings with a classification of Q3 in Urology, it stands at a significant position (Rank #71 out of 120) with a 41st percentile performance, highlighting its role in contributing to the global discourse in urological medicine. The journal provides open access options, ensuring that high-quality research is readily available to a broad audience, fostering collaboration and innovation. Publishing significant studies from various converged years, including from 1984 to 1999 and more recently from 2006 to 2024, Indian Journal of Urology is essential for professionals seeking to stay updated with the latest advances and best practices in urology.

European Urology Oncology

Delivering high-quality, peer-reviewed content for medical excellence.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.

Minerva Obstetrics and Gynecology

Fostering collaboration for a healthier future.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-606XFrequency: 6 issues/year

Minerva Obstetrics and Gynecology, an esteemed journal published by EDIZIONI MINERVA MEDICA, serves as a vital resource in the field of obstetrics and gynecology. With an ISSN of 2724-606X and an E-ISSN of 2724-6450, this open access journal aims to disseminate high-quality research and clinical studies that address contemporary challenges and advancements in women's health. Since its inception in 2021, Minerva Obstetrics and Gynecology has garnered recognition within the academic community, achieving a commendable Q3 ranking in the 2023 category of Obstetrics and Gynecology, and placing at the 54th percentile among peers in its Scopus rankings. The journal not only facilitates the exchange of innovative ideas but also encourages collaboration among researchers, healthcare professionals, and students from around the globe. With a commitment to excellence, it aims to address significant topics that impact clinical practice, ensuring that practitioners remain informed about the latest evidence-based practices. For researchers and practitioners aiming to contribute to the advancement of gynecological and obstetric medicine, Minerva Obstetrics and Gynecology represents a prominent platform for publication and engagement.

Journal of Gastrointestinal Oncology

Advancing knowledge in gastrointestinal cancer research.
Publisher: AME PUBLISHING COMPANYISSN: 2078-6891Frequency: 6 issues/year

The Journal of Gastrointestinal Oncology, published by AME Publishing Company, is a leading open-access journal that focuses on the complex interplay between gastroenterology and oncology. Established in 2012 and converging into a reputable academic platform through 2024, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements in the diagnosis, treatment, and management of gastrointestinal cancers. With an ISSN of 2078-6891 and an E-ISSN of 2219-679X, this journal presents articles that are rigorously peer-reviewed, ensuring high-quality content that meets the demands of the scientific community. Despite its current categorization in the Q3 quartile for both Gastroenterology and Oncology as of 2023, it consistently strives to improve its impact and relevance, reflected in its Scopus rankings and percentile metrics. Publishing noteworthy research, reviews, and case studies, the Journal of Gastrointestinal Oncology is instrumental in addressing significant challenges in the field, making it a must-read for those dedicated to advancing knowledge and practice in gastrointestinal oncology.

Gynecology and Minimally Invasive Therapy-GMIT

Transforming gynecology through open-access knowledge sharing.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2213-3070Frequency: 4 issues/year

Gynecology and Minimally Invasive Therapy (GMIT) is a distinguished open-access journal published by Wolters Kluwer Medknow Publications, focused on advancing the field of obstetrics and gynecology through innovative research and insights into minimally invasive techniques. With an ISSN of 2213-3070 and E-ISSN 2213-3089, GMIT has established itself as a prominent platform for researchers and clinicians alike, facilitating the dissemination of pivotal findings since its inception in 2012. The journal currently ranks in the Q3 category for Obstetrics and Gynecology in 2023, with a Scopus ranking of #120/209, placing it in the 42nd percentile within its field. Based in Mumbai, India, it has embraced open access since 2016, promoting the wide availability of groundbreaking research to enhance clinical practices and improve patient outcomes. GMIT aims to foster knowledge sharing and interdisciplinary collaboration, vital for professionals in the rapidly evolving landscape of gynecological care.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Advancing urologic cancer care through innovative research.
Publisher: ELSEVIER SCIENCE INCISSN: 1078-1439Frequency: 12 issues/year

Urologic Oncology - Seminars and Original Investigations is a premier journal published by Elsevier Science Inc, dedicated to advancing the field of urologic oncology through high-quality, peer-reviewed research and insightful scholarly discussions. With an ISSN of 1078-1439 and an E-ISSN of 1873-2496, this journal has established itself as a vital resource for professionals, researchers, and students alike since its inception in 1995. Currently holding a Q2 ranking in Oncology and a prestigious Q1 in Urology for 2023, it ranks 28th out of 120 in Urology and 177th out of 404 in Oncology within Scopus, underscoring its relevance and impact in these critical fields. While the journal operates under a subscription model, it continues to deliver compelling and transformative research aimed at enhancing patient outcomes in urologic oncology. With a focus on innovative therapies, diagnostic advancements, and clinical trials, the journal contributes significantly to ongoing dialogue and development in urologic health care.

ANNALS OF SURGICAL ONCOLOGY

Connecting research and practice for better patient care.
Publisher: SPRINGERISSN: 1068-9265Frequency: 13 issues/year

The ANNALS OF SURGICAL ONCOLOGY, published by SPRINGER, stands as a leading journal dedicated to advancing the field of surgical oncology. With an ISSN of 1068-9265 and an E-ISSN of 1534-4681, this esteemed publication features high-quality research from 1994 to 2024, contributing significantly to the scientific dialogue surrounding surgical techniques, treatment innovations, and patient outcomes within the oncology community. The journal has earned a prestigious Q1 ranking in Surgery and a Q2 in Oncology for 2023, reflecting its pivotal role in influencing clinical practices and research in these fields. According to Scopus metrics, it ranks #51 out of 551 in Medicine Surgery and #133 out of 404 in Medicine Oncology, underscoring its academic rigor and impact. Despite being a subscription-based journal, the depth of knowledge disseminated through its pages is invaluable for researchers, professionals, and students aiming to stay at the forefront of surgical oncology advancements.